BSEM
Price:
$4.74
Market Cap:
$80.50M
BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States. It offers Vendaje, a structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje AC, a thicker structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje OPTIC, a structural tissue allograft used as a protective covering during the repair of ocular surfaces; American Amnion AC, a human connective tissue matrix for homologous use; and American Amnion, a human connective tissue matrix for homologous use. The company was formerly known as Ca...[Read more]
Industry
Biotechnology
IPO Date
2015-03-17
Stock Exchange
NASDAQ
Ticker
BSEM
According to BioStem Technologies, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 74.77M. This represents a change of 48.62% compared to the average of 50.31M of the last 4 quarters.
The mean historical Enterprise Value of BioStem Technologies, Inc. over the last ten years is 55.84M. The current 74.77M Enterprise Value has changed 13.29% with respect to the historical average. Over the past ten years (40 quarters), BSEM's Enterprise Value was at its highest in in the March 2024 quarter at 256.62M. The Enterprise Value was at its lowest in in the March 2019 quarter at 0.
Average
55.84M
Median
35.85M
Minimum
14.18M
Maximum
208.10M
Discovering the peaks and valleys of BioStem Technologies, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 170.86%
Maximum Annual Enterprise Value = 208.10M
Minimum Annual Increase = -81.97%
Minimum Annual Enterprise Value = 14.18M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 37.52M | -81.97% |
| 2024 | 208.10M | 145.38% |
| 2023 | 84.81M | 120.75% |
| 2022 | 38.42M | 170.86% |
| 2021 | 14.18M | -24.68% |
| 2020 | 18.83M | -32.99% |
| 2019 | 28.10M | -6.21% |
| 2018 | 29.97M | -53.41% |
| 2017 | 64.31M | 88.18% |
| 2016 | 34.18M | 105.01% |
The current Enterprise Value of BioStem Technologies, Inc. (BSEM) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
110.14M
5-year avg
76.61M
10-year avg
55.84M
BioStem Technologies, Inc.’s Enterprise Value is greater than IXICO plc (15.31M), greater than Nicox S.A. (28.93M), greater than Alterity Therapeutics Limited (60.75M), greater than Satellos Bioscience Inc. (41.10M), less than Clara Technologies Corp. (11.24B), less than Actinogen Medical Limited (222.25M), greater than MedX Health Corp (20.15M), greater than Imugene Limited (26.68M), greater than ZIVO Bioscience, Inc. (12.90M), greater than Vicapsys Life Sciences, Inc. (28.01M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 15.31M | $6.51M | |
| 28.93M | $29.17M | |
| 60.75M | $87.00M | |
| 41.10M | $96.62M | |
| 11.24B | $10.50M | |
| 222.25M | $130.11M | |
| 20.15M | $8.20M | |
| 26.68M | $22.04M | |
| 12.90M | $12.44M | |
| 28.01M | $27.52M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioStem Technologies, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BioStem Technologies, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is BioStem Technologies, Inc.'s Enterprise Value?
What is the highest Enterprise Value for BioStem Technologies, Inc. (BSEM)?
What is the 3-year average Enterprise Value for BioStem Technologies, Inc. (BSEM)?
What is the 5-year average Enterprise Value for BioStem Technologies, Inc. (BSEM)?
How does the current Enterprise Value for BioStem Technologies, Inc. (BSEM) compare to its historical average?